RT Journal Article
SR Electronic
T1 A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP e20
OP e24
DO 10.3949/ccjm.84.s4.05
VO 84
IS 12 suppl 4
A1 Waksman, Ron
YR 2017
UL http://www.ccjm.org/content/84/12_suppl_4/e20.abstract
AB Drug-eluting stents (DES) are increasingly being used as a less invasive alternative to coronary artery bypass grafting. Early generation DES had durable polymers that provided acceptable efficacy outcomes but had high rates of stent thrombosis leading to myocardial infarction and death. Second-generation DES have improved outcomes by reducing stent thrombosis and recurrent stenosis. Newer DES with biodegradable polymers have similar efficacy as second-generation DES, but have higher rates of stent thrombosis. This review compares outcomes of bioresorbable scaffolds and looks at stent technology developments that may improve outcomes.